Answers are grounded in this paper and cite their sources.
The high accuracies for Aβ pathology and future AD dementia using fully automated instruments are promising for implementing plasma biomarkers in clinical trials and clinical routine.
No takes yet. Share an insight, caveat, or question.
Palmqvist et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: